Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerulonephritis, Membranous”

158 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 158 results

Post-approval studies (Phase 4)Looking for participantsNCT06573411
What this trial is testing

Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
First Affiliated Hospital, Sun Yat-Sen University 116
Very early researchLooking for participantsNCT07389499
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases

Who this might be right for
IgA Nephropathy (IgAN)Membranous NephropathyANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN)+2 more
Grit Biotechnology 30
Not applicableUnknownNCT05797038
What this trial is testing

Study on the Application of Hyperspectral Imaging Technique in the Treatment of IMN by TAC

Who this might be right for
Idiopathic Membranous NephropathyTacrolimusHyperspectral Imaging
Qianfoshan Hospital 40
Not applicableLooking for participantsNCT07018024
What this trial is testing

Anti-Glomerular Basement Membrane Disease

Who this might be right for
Anti-Glomerular Basement Membrane Disease
Region Skane 300
Post-approval studies (Phase 4)Study completedNCT00518219
What this trial is testing

To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)

Who this might be right for
Membranous Nephropathy
Nanjing University School of Medicine 68
Testing effectiveness (Phase 2)Study completedNCT03453619
What this trial is testing

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

Who this might be right for
IgA NephropathyLupus NephritisMembranous Nephropathy+2 more
Apellis Pharmaceuticals, Inc. 21
Not applicableUnknownNCT05656963
What this trial is testing

The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD

Who this might be right for
Glomerulonephritis, MembranousDiabetic NephropathiesThrombelastography+1 more
Yipeng Liu 741
Not applicableEnded earlyNCT03475602
What this trial is testing

Membranous Nephropathy-associated Serological Antibody Predict the Prognosis of Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Guangdong Provincial People's Hospital 85
Not applicableLooking for participantsNCT05505500
What this trial is testing

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

Who this might be right for
Fluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more
University of Michigan 150
Not applicableNot Yet RecruitingNCT07010250
What this trial is testing

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

Who this might be right for
ANCA Associated VasculitisExtramembranous GlomerulopathyNephrotic Syndrome, Minimal Change+4 more
Assistance Publique - Hôpitaux de Paris 146
Very early researchLooking for participantsNCT07203404
What this trial is testing

Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

Who this might be right for
SLELNANCA Associated Vasculitis+5 more
Nanjing Bioheng Biotech Co., Ltd. 84
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT06642909
What this trial is testing

A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
BioRay Pharmaceutical Co., Ltd. 135
Not applicableLooking for participantsNCT04571658
What this trial is testing

NEPTUNE Match Study

Who this might be right for
Nephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more
University of Michigan 375
Large-scale testing (Phase 3)Looking for participantsNCT05914155
What this trial is testing

Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome

Who this might be right for
Glomerulonephritis, MembranousNephrotic Syndrome，Idiopathic
Shoichi Maruyama MD PhD 88
Post-approval studies (Phase 4)WithdrawnNCT01926054
What this trial is testing

ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis

Who this might be right for
SLE Glomerulonephritis Syndrome, WHO Class V
Ohio State University
Large-scale testing (Phase 3)Study completedNCT00404794
What this trial is testing

Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis

Who this might be right for
Lupus NephritisGlomerulonephritis, Membranous
Hospital Authority, Hong Kong 20
Early research (Phase 1)Ended earlyNCT00479622
What this trial is testing

Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Wyeth is now a wholly owned subsidiary of Pfizer 20
Large-scale testing (Phase 3)Looking for participantsNCT06470191
What this trial is testing

A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

Who this might be right for
Primary Membranous Nephropathy
Shanghai Jiaolian Drug Research and Development Co., Ltd 216
Testing effectiveness (Phase 2)Study completedNCT06513338
What this trial is testing

Complement C5 mAb in the Treatment of Anti-GBM Disease

Who this might be right for
Autoimmune Diseases
Peking University First Hospital 16
Load More Results